As the clinical research industry continues to grow, an effective site management organization has become critical to ensuring timely and successful trial outcomes. To meet this demand, Neutra launched its Site Management Organization (SMO) pilot program in August 2024 in an effort to transition away from consulting in the industry to partnering and operating private practice research site.

“By adding the SMO Services, we are unlocking additional revenue drivers from partners and expanding to new opportunities internationally,” said Sydney Jim, CEO of Neutra Corp. “We have a proven track record of providing corporate services in this market, and now we’re excited to introduce our own program that integrates the patient-first approach with advanced technology, standardized processes, and quality data to clinical research.”

Key Features of the Pilot Program include:

• Comprehensive Site Support: The program offers full-spectrum support for clinical trial sites, including staff training, regulatory compliance guidance, and patient recruitment strategies.
• Technology Integration: Neutra Corp’s pilot program utilizes multiple digital platforms that give the ability to leverage artificial intelligence (AI) and machine learning to optimize workflow management, real-time data tracking, and seamless communication.
• Standardized Processes: By implementing consistent procedures across all participating sites, the program aims to reduce variability, improve data quality, and enhance protocol adherence.
• Patient-Centric Approach: The pilot program prioritizes patient engagement and retention through tailored outreach initiatives and improved accessibility to trial resources.
• Patient-Centric Clinical Research: Neutra Corp is committed to transforming clinical research experience by putting patients at the center of the process. The program emphasizes patient education, transparent communication, and personalized support to ensure a positive and empowering trial journey for every participant.

The pilot program has already demonstrated success at a research site in Richmond, Texas, United States, delivering measurable improvements in trial efficiency and patient satisfaction. The goal for 2025 is to have a full-scale launch of Neutra Corp’s Site Management Organization division.

About Neutra Corp

Neutra Corp. is a health, wellness and life sciences company specializing both in the development and marketing of natural wellness solutions and the life sciences sector of Clinical Research. For investing information and performance data, please visithttps://www.neutrainc.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, a description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Sydney Jim
3072281488
info@neutrainc.com

View the original release on www.newmediawire.com

COMTEX_462236984/2549/2025-01-27T09:00:35